This research emphasises the importance of combating corruption in pharmaceutical procurement to ensure equitable access to quality medicines. It discusses the vulnerability of procurement to corruption, regardless of government level or health system type, and underscores the necessity of integrating accountability, transparency, and anti-corruption measures. The paper concludes that mechanisms like open contracting and integrity pacts are effective in mitigating corruption risks in this context.

Go to article:

The risk of corruption in public pharmaceutical procurement: hHow anti-corruption, transparency and accountability measures may reduce this risk

Kohler, J. C., Dimancesco, D., (2020) Global Health Action